Questions? Feedback? powered by Olark live chat software
All Site

In Vitro’s Response to COVID-19

In Vitro Technologies is committed to providing essential products to the scientific and medical community, especially during the current, quickly changing circumstances caused by the corona virus (COVID-19) outbreak.


Nobel Prize winners leverage Seahorse XF Technology

In October of 2019, the Nobel Assembly announced the award of the 2019 Nobel Prize jointly to William G. Kaelin, Jr., Sir Peter J. Ratcliffe and Gregg L. Semenza in Physiology or Medicine. This award is to acknowledge their scientific discoveries of how cells sense and adapt to oxygen availability.


RNA expression like you’ve never seen it before

In Vitro Technologies are proud to announce two upcoming seminars detailing ACD Bio RNAscope® technology, a unique technology enabling RNA target expression analysis within intact cells and tissues with high sensitivity and specificity. 


ATCC Launches First Portal of Whole-genome Sequences Based on Authenticated Biological Standards

ATCC launched its new ATCC Genome Portal, a publicly available database of reference-quality genome sequences matched to authenticated ATCC biological materials that will help researchers interpret and reproduce their results with confidence. The portal, which launched with an initial 250 genome sequences of widely used bacterial strains, delivers on ATCC’s Enhanced Authentication Initiative, a component of the first of five core pledges under the Incredible 2020 Initiative aimed at increasing reproducibility in biological research.


ATCC Launches Mouse Cell Line Authentication Service

ATCC today announced the launch of a new authentication service that will allow researchers to easily confirm the identity of mouse cell lines. Developed in partnership with the National Institutes for Standards and Technology (NIST), the service demonstrates ATCC’s continued leadership in developing global biological standards.


A social and networking event by The BioProcessing Network

The Bioprocessing Network Australia (BPN) has selected Probiotics Australia as the site for the next QLD satellite event now that Probiotics Australia has been launched and started production.

 Probiotics Australia is a purpose built, cutting-edge bio-manufacturing facility, located in Ormeau, Queensland, it was officially opened in May 2019. The TGA cGMP licensed facility houses research, development and production laboratories in addition to sizable warehousing and offices. The site is also certified by Australian Certified Organic, HACCP approved, and FDA registered.

Time: 6.00pm – 8.00pm 
Wednesday 18th of September
Location: Probiotics Australia Facility 
24 Blanck Street, Ormeau QLD 4208
RSVP by the 11th of September 

Start with Authenticated Standards

ATCC Pledges to Advance Authentication

Are you willing to stake the integrity of your research on potentially unreliable starting materials? Your incredible advancements are too important to risk.


Next-Generation Biological Models: Revolutionizing Cancer Research

In ATCC's latest short documentary film, “Next-Generation Biological Models: Revolutionizing Cancer Research,” they focus on the Human Cancer Models Initiative (HCMI), a groundbreaking international research collaboration to transform cancer research and therapeutic development.

Total: 64 posts